Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers
SAN DIEGO, Jan. 26, 2015 /PRNewswire/ -- Epic Sciences, a precision diagnostics company dedicated to improving the treatment of cancer, today announced that Murali Prahalad, Ph.D., president and CEO, is scheduled to present at the Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which is taking place at the Computer History Museum in Mountain View, Calif. on January 26-28, 2015.
Dr. Prahalad will give a presentation entitled, "CTCs Come of Age as Biomarkers." Last year, Epic Sciences was a finalist in the PMWC's Most Promising Company Award Competition.
The details of the presentation are as follows:
Date: Tuesday, January 27, 2015
Track 1: Applying Complementary Technologies Towards Biomarker Discovery
Time: 3:45 PM PST
Co-hosted with Stanford Health Care and Oracle in Silicon Valley, PMWC 2015 will gather close to 1,000 multidisciplinary attendees and key stakeholders from the business, government, healthcare delivery, research and technology arenas to examine the advances and challenges of personalized medicine through a practical lens.
About Epic Sciences
Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer. Epic's mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient's journey. The company was founded on a powerful platform to identify and characterize rare cells, including circulating tumor cells (CTCs). Epic's no cell left behind™ technology helps match patients to targeted therapies and monitor for drug resistance, so that the best treatment path can be chosen at every clinical decision point. Today, we partner with leading pharmaceutical companies and major cancer centers around the world. Epic's goal is to commercialize our technology to increase the success rate of cancer drugs in clinical trials and improve patient outcomes by providing physicians real-time information to guide treatment choices.
Further information is available on the Company's website, www.epicsciences.com. Stay in touch on Twitter @EpicSciences or on Facebook.com/EpicSciences.
SOURCE Epic Sciences
Share this article